Andrew Talal, University at Buffalo (IMAGE) University at Buffalo Caption Talal led the study, which is the first to track in real-time, how the drug telaprevir inhibits viral replication in the liver. Credit Douglas Levere, University at Buffalo Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.